Last quarter (Q4 2023), Ocugen's total revenue was $1.01M, an increase of Infinity% from the same quarter last year. In Q4, Ocugen's net income was $-11.92M. See Ocugen’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 7.05M	$ 6.04M	-	-	$ 43.00K	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 7.05M	$ 6.04M	-	-	-	-
Operating Expense	$ 67.05M	$ 71.57M	$ 84.87M	$ -58.03M	$ 14.33M	$ 14.16M
Operating Income	$ -60.00M	$ -65.53M	$ -84.87M	$ -58.03M	$ -14.29M	$ -14.16M
Net Non Operating Interest Income Expense	$ 2.10M	$ 2.50M	$ 1.40M	$ -389.00K	$ -721.00K	$ -1.77M
Other Income Expense	$ -1.49M	$ -2.45M	$ -3.52M	$ 310.00K	$ -6.82M	$ -4.31M
Pretax Income	$ -58.50M	$ -63.08M	$ -81.35M	$ -58.42M	$ -21.82M	$ -20.24M
Tax Provision	-	-	-	$ -52.00K	$ 0.00	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -58.50M	$ -63.08M	$ -81.35M	$ -58.37M	$ -34.37M	$ -20.24M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 67.05M	$ 71.57M	$ 84.87M	$ -58.03M	$ 14.33M	$ 14.16M
Net Income From Continuing And Discontinued Operation	$ -58.50M	$ -63.08M	$ -81.35M	$ -58.37M	$ -21.82M	$ -20.24M
Normalized Income	$ -44.12M	$ -45.35M	$ -64.27M	-	$ -14.82M	$ -16.71M
Interest Expense	-	-	-	-	$ 721.00K	$ 1.77M
EBIT	$ -58.50M	$ -63.08M	$ -81.35M	$ -58.42M	$ -21.10M	$ -18.47M
EBITDA	$ -57.83M	$ -62.56M	$ -80.97M	$ -58.19M	$ -21.00M	$ -18.41M

Currency in USD

Ocugen Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing